Skip to content
Head to head

Globus Medical vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: GMED · ABT

Updated moments ago

1-year performance, rebased to 100

GMED -20.0%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
GMEDABT
Snapshot
SectorMedical DevicesMedical Devices
Last price66.89103.00
Change today-2.49%-0.84%
1-year return-18.7%-15.4%
Market cap$8.86B$178.39B
52-week range66.63 – 101.4080.89 – 126.70
Valuation
P/E (TTM)16.4838.29
P/E percentile, own 5-yr range1st99th
P/B1.853.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)3.923.72
Net profit (TTM)$519.29M$6.44B
Revenue (TTM)$3.14B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)-0.7%+14.5%
Gross margin69.1%56.9%
Operating margin22.8%13.8%
Net margin17.8%9.7%
Free cash flow (TTM)$756.80M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership96.6%81.2%
Insider activity (12mo)28 buy / 21 sell36 buy / 12 sell
Short interest (% of float)7.0%1.1%
Analyst consensus70% buy / 30% hold (10)93% buy / 7% hold (15)
Analyst price target$93 (+39%)$122 (+18%)
StockVane view
StockVane Quant RatingD (20)D (22)
Company
Employees6,000115,000
Founded20031900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.